Max E Oscherwitz (Max Oscherwitz)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Chronic Kidney Disease

Patient Reported Outcomes

Ejection Fraction

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

International journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Max E Oscherwitz, Brandon M Godinich, Raj H Patel, Steven Richard Feldman
Effects of Private Equity on Dermatologic Quality of Patient Care. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Matthew L Hrin, Max E Oscherwitz, Joseph L Jorizzo, Steven R Feldman, William W Huang
Evaluation of pentoxifylline in the treatment of necrobiosis lipoidica: outcomes in 10 patients. International journal of dermatology 63 (3) (2024)
Max E Oscherwitz, Matthew L Hrin, Zachary J Neuberg, Joseph L Jorizzo
Should systemic corticosteroids be relatively contraindicated in granuloma annulare? Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Max E Oscherwitz, John Trinidad, Steven T Chen
Necrotic skin ulcerations caused by xylazine in people who inject intravenous drugs. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Max E Oscherwitz, John Trinidad, Steven T Chen
Necrotic skin ulcerations caused by xylazine in people who inject intravenous drugs. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (6) (2024)
Matthew L Hrin, Max E Oscherwitz, Joseph L Jorizzo, Steven R Feldman, William W Huang
Evaluation of pentoxifylline in the treatment of necrobiosis lipoidica: outcomes in 10 patients. International journal of dermatology (2024)
Matthew L Hrin, Max E Oscherwitz, Joseph L Jorizzo, Steven R Feldman, William W Huang
Evaluation of pentoxifylline in the treatment of necrobiosis lipoidica: outcomes in 10 patients. International journal of dermatology 63 (3) (2024)